| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 25300 | 2017 |
| A calcium antagonist vs a non–calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study … CJ Pepine, EM Handberg, RM Cooper-DeHoff, RG Marks, P Kowey, ... Jama 290 (21), 2805-2816, 2003 | 1957 | 2003 |
| Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease RM Cooper-DeHoff, Y Gong, EM Handberg, AA Bavry, SJ Denardo, ... Jama 304 (1), 61-68, 2010 | 844 | 2010 |
| Obesity paradox in patients with hypertension and coronary artery disease S Uretsky, FH Messerli, S Bangalore, A Champion, RM Cooper-DeHoff, ... The American journal of medicine 120 (10), 863-870, 2007 | 669 | 2007 |
| Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take … M Gulati, RM Cooper-DeHoff, C McClure, BD Johnson, LJ Shaw, ... Archives of internal medicine 169 (9), 843-850, 2009 | 639 | 2009 |
| Withdrawn: postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results … LJ Shaw, CN Bairey Merz, R Azziz, FZ Stanczyk, G Sopko, GD Braunstein, ... The Journal of Clinical Endocrinology & Metabolism 93 (4), 1276-1284, 2008 | 629 | 2008 |
| Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST) R Kolloch, UF Legler, A Champion, RM Cooper-DeHoff, E Handberg, ... European heart journal 29 (10), 1327-1334, 2008 | 492 | 2008 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ... Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014 | 458 | 2014 |
| The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ... Clinical Pharmacology & Therapeutics 92 (1), 112-117, 2012 | 362 | 2012 |
| Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci R Saxena, CC Elbers, Y Guo, I Peter, TR Gaunt, JL Mega, MB Lanktree, ... The American Journal of Human Genetics 90 (3), 410-425, 2012 | 322 | 2012 |
| Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics JD Duarte, RM Cooper-DeHoff Expert review of cardiovascular therapy 8 (6), 793-802, 2010 | 305 | 2010 |
| Hypertension across a woman’s life cycle NK Wenger, A Arnold, CN Bairey Merz, RM Cooper-DeHoff, ... Journal of the American College of Cardiology 71 (16), 1797-1813, 2018 | 302 | 2018 |
| Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci FW Asselbergs, Y Guo, EPA Van Iperen, S Sivapalaratnam, V Tragante, ... The American Journal of Human Genetics 91 (5), 823-838, 2012 | 297 | 2012 |
| The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. MB Grant, RN Mames, C Fitzgerald, KM Hazariwala, R Cooper-Dehoff, ... Diabetes Care 23 (4), 504-509, 2000 | 281 | 2000 |
| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 271 | 2018 |
| Method and system for interactive prescription and distribution of prescriptions in conducting clinical studies M Colon, RG Marks, CJ Pepine, EM Handberg-Thurmond, ... US Patent 5,991,731, 1999 | 253 | 1999 |
| In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with … DF Pauly, BD Johnson, RD Anderson, EM Handberg, KM Smith, ... American heart journal 162 (4), 678-684, 2011 | 251 | 2011 |
| Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension CJ Pepine, E Handberg-Thurmond, RG Marks, M Conlon, ... Journal of the American College of Cardiology 32 (5), 1228-1237, 1998 | 225 | 1998 |
| Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy AA Bavry, RD Anderson, Y Gong, SJ Denardo, RM Cooper-DeHoff, ... Hypertension 55 (1), 48-53, 2010 | 210 | 2010 |
| Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy SJ Denardo, Y Gong, WW Nichols, FH Messerli, AA Bavry, ... The American journal of medicine 123 (8), 719-726, 2010 | 201 | 2010 |
